"It would be really brash if Suresh comes back to the market for cash after all of the new hires."

McWitty, I would say it will be mildly disappointing if we have to go back to the market.  Based on what is public information, POET is not cash flow positive (or even close).  That's been the case forever, and certainly appears that state of affairs will continue for some period going forward.  So it would not be at all surprising to have to raise more funds and one way is to sell stock.  It would be fantastic if POET could get some meaningful cash in the door in less dilutive ways, and perhaps that will be the case.

I have no problem with them hiring the people (or buying equipment) that they need to get us where we want to be from a technical standpoint, and to help us promote the hell out of the interposer once it's ready.  No telling when that will be, though, two months, six months, 18 months?  We all hope it's very close, but that's mere speculation, based on not outlandish circumstantial evidence.

So, if we need money, and the only place to get it is the market, then we need to accept this - it's pretty much a fact of life for developmental tech/biotech.